Company performance
Add to research
Current Price
as of May 21, 2025$15.70
P/E Ratio
N/A
Market Cap
$1.6B
Description
Add to research
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Metrics
Add to research
Overview
- HQNew Haven, CT
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerBHVN
- Price$15.7-3.38%
Trading Information
- Market cap$1.60B
- Float87.32%
- Average Daily Volume (1m)2,602,845
- Average Daily Volume (3m)1,847,830
- EPS-$9.37
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$221.68M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$220.55M
- EV$2.16B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B6.18
- Debt/Equity13.69
Documents
Add to research
Factset Street Account
Factset